Department of Epidemiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, China.
J Cancer Res Clin Oncol. 2010 Jul;136(7):975-9. doi: 10.1007/s00432-009-0742-x. Epub 2009 Dec 10.
Published data on the association between manganese superoxide dismutase (MnSOD) Val(16)Ala polymorphism and prostate cancer (PCA) risk are inconclusive. To derive a more precise estimate of the association between them, a meta-analysis was performed.
PubMed and Embase were searched. All eligible studies were retrieved. The pooled odds ratio (OR) with 95% confidence interval (CI) for PCA risk associated with Val/Ala versus Val/Val, Ala/Ala versus Val/Val, dominant model (Ala/Ala + Val/Ala vs. Val/Val), and recessive model (Ala/Ala vs. Val/Ala + Val/Val) were estimated, respectively.
A total of 12 studies including 8,962 subjects were involved in this meta-analysis. Overall, the meta-analysis indicated that significantly elevated cancer risk was associated with Ala variant genotype when all the eligible studies were pooled into the meta-analysis (for Val/Ala vs. Val/Val: OR = 1.11, 95% CI = 1.00-1.24; for Ala/Ala vs. Val/Val: OR = 1.22, 95% CI = 1.00-1.49; for dominant model: OR = 1.14, 95% CI = 1.03-1.26). In the subgroup analysis by ethnicity, statistically significant increased risks were found among Caucasians with Ala allele (for Val/Ala vs. Val/Val: OR = 1.12, 95% CI = 1.00-1.25; for dominant model: OR = 1.14, 95% CI = 1.02-1.26). However, no significant associations were found in Africans.
This meta-analysis suggests that the Ala allele of the MnSOD gene was a low-penetrance susceptible gene in PCA development, especially in Caucasians.
关于锰超氧化物歧化酶(MnSOD)Val(16)Ala 多态性与前列腺癌(PCA)风险之间的关联,已有发表的数据尚无定论。为了更准确地评估它们之间的关联,进行了荟萃分析。
检索了 PubMed 和 Embase。检索到所有合格的研究。分别估计与 Val/Ala 与 Val/Val、Ala/Ala 与 Val/Val、优势模型(Ala/Ala + Val/Ala 与 Val/Val)和隐性模型(Ala/Ala 与 Val/Ala + Val/Val)相关的 PCA 风险的合并比值比(OR)及其 95%置信区间(CI)。
共有 12 项研究(共 8962 例患者)纳入本荟萃分析。总的来说,当将所有合格的研究纳入荟萃分析时,荟萃分析表明 Ala 变异基因型与癌症风险显著升高(对于 Val/Ala 与 Val/Val:OR = 1.11,95%CI = 1.00-1.24;对于 Ala/Ala 与 Val/Val:OR = 1.22,95%CI = 1.00-1.49;对于优势模型:OR = 1.14,95%CI = 1.03-1.26)。在按种族进行的亚组分析中,在携带 Ala 等位基因的白种人中发现了统计学上显著的更高风险(对于 Val/Ala 与 Val/Val:OR = 1.12,95%CI = 1.00-1.25;对于优势模型:OR = 1.14,95%CI = 1.02-1.26)。然而,在非洲人中未发现明显的相关性。
本荟萃分析表明,MnSOD 基因的 Ala 等位基因是 PCA 发展中的低外显度易感基因,尤其是在白种人中。